ANVS Annovis Bio, Inc.
Healthcare$2.23+3.72%ClosedMarket Cap: $43.9M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$25.67
Target (Median)
$26.00
Target Range
$21.00 - $30.00
Upside from current price: 1051.1%
Rating Distribution
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-14 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-09-30 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-09-03 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-09 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.22 | $16.7M | 1 |
| Sun Dec 31 | $-1.61 | $50.5M | 2 |
| Mon Dec 31 | $0.58 | $297.4M | 1 |
| Tue Dec 31 | $4.14 | $619.0M | 1 |